@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-MTGZS373-L mesh:pharmacologicalAction jvr:-BT63B9BM-V .
jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-SRWCVV3K-8
  skos:prefLabel "Agents de l'appareil respiratoire"@fr, "Respiratory System Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-BT63B9BM-V .

jvr:-DWSP65S4-2 mesh:pharmacologicalAction jvr:-BT63B9BM-V .
jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-ZVWGS8PB-F mesh:pharmacologicalAction jvr:-BT63B9BM-V .
jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-TP3WKJRR-N mesh:pharmacologicalAction jvr:-BT63B9BM-V .
jvr:-G6HDQ6MW-G mesh:pharmacologicalAction jvr:-BT63B9BM-V .
jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-BT63B9BM-V
  a mesh:Descriptor, skos:Concept ;
  mesh:allowableQualifier jvr:-M63HSDM7-1, jvr:-G30ZJ446-J, jvr:-T9HQD7ST-J, jvr:-SBNWSM1T-R, jvr:-NB0XHT3S-N, jvr:-W6SQV79N-S, jvr:-FWD2BGQ0-9, jvr:-NFTHND7Q-8, jvr:-HQRFT0C6-B, jvr:-Q3979798-W, jvr:-S0CS1X5R-5, jvr:-THHNVC7V-3, jvr:-R3QWLHRG-V, jvr:-L6C0XPHT-4, jvr:-NHL3D2X0-S, jvr:-D0F21513-5, jvr:-H7K65Q8S-Z, jvr:-CB30NGKB-3, jvr:-BT300B3G-Q, jvr:-TJHVZCRZ-0, jvr:-NKM836P1-M, jvr:-XV06LPML-W, jvr:-WK5F724J-1, jvr:-R0ZCQ8X6-J ;
  skos:hiddenLabel "Agents décongestionnants"@fr, "Vasoconstricteur nasal"@fr, "Vasoconstricteurs par voie nasale"@fr, "Decongestants"@en, "Decongestant"@en, "Décongestionnants"@fr, "Vasoconstricteurs nasaux"@fr, "Vasoconstrictors, Nasal"@en, "Médicaments décongestionnants"@fr, "Vasoconstrictor Agents, Nasal"@en ;
  skos:altLabel "Nasal Decongestant"@en, "Décongestionnants par voie nasale"@fr, "Décongestionnants nasaux"@fr ;
  dc:modified "2020-05-27"^^xsd:date ;
  dc:created "1999-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  skos:broader jvr:-R9SB4WRS-X, jvr:-SRWCVV3K-8 ;
  skos:prefLabel "Décongestionnant nasal"@fr, "Nasal Decongestants"@en ;
  dc:established "1967-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D014663> ;
  skos:definition "Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)"@en .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R9SB4WRS-X
  skos:prefLabel "Vasoconstricteurs"@fr, "Vasoconstrictor Agents"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-BT63B9BM-V .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VS58B4MJ-6 mesh:pharmacologicalAction jvr:-BT63B9BM-V .
jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .